156 related articles for article (PubMed ID: 37180662)
1. Identification of
Zhao H; He X; Ma Z
Transl Cancer Res; 2023 Apr; 12(4):1021-1032. PubMed ID: 37180662
[TBL] [Abstract][Full Text] [Related]
2. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
3. Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma.
Zhou C; Chen Z; Xiao B; Xiang C; Li A; Zhao Z; Li H
Front Cell Dev Biol; 2022; 10():951363. PubMed ID: 36092720
[No Abstract] [Full Text] [Related]
4. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer.
Ahmad M; Hameed Y; Khan M; Usman M; Rehman A; Abid U; Asif R; Ahmed H; Hussain MS; Rehman JU; Asif HM; Arshad R; Atif M; Hadi A; Sarfraz U; Khurshid U
Braz J Biol; 2021; 84():e250575. PubMed ID: 34852135
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma.
Zhang K; Zhou J; Wu T; Tian Q; Liu T; Wang W; Zhong H; Chen Z; Xiao X; Wu G
Aging (Albany NY); 2022 Jul; 14(14):5895-5907. PubMed ID: 35896011
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognosis analysis of GINS subunits in human breast cancer.
Li H; Cao Y; Ma J; Luo L; Ma B
Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
[TBL] [Abstract][Full Text] [Related]
8. Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.
Tang L; Yu W; Wang Y; Li H; Shen Z
Clin Transl Oncol; 2019 Dec; 21(12):1624-1633. PubMed ID: 30963468
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
[TBL] [Abstract][Full Text] [Related]
11. A 4-miRNA signature act as a novel prognostic biomarker in patients with Sarcoma.
Chen X; Cao L; Xie N; Xu X; Liu M; Wang K
Transl Cancer Res; 2019 Aug; 8(4):1412-1422. PubMed ID: 35116884
[TBL] [Abstract][Full Text] [Related]
12. Construction of circRNA-miRNA-mRNA network and identification of novel potential biomarkers for non-small cell lung cancer.
Yang J; Hao R; Zhang Y; Deng H; Teng W; Wang Z
Cancer Cell Int; 2021 Nov; 21(1):611. PubMed ID: 34801043
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.
Yin C; Zhang J; Shen M; Gu Z; Li Y; Xue W; Shi J; Huang W
Front Oncol; 2020; 10():1520. PubMed ID: 32974187
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
Liu T; You X; Sui J; Shen B; Zhang Y; Zhang XM; Yang S; Yao YZ; Yang F; Yin LH; Pu YP; Liang GY
J Cell Biochem; 2019 May; 120(5):7185-7198. PubMed ID: 30390338
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Identifies a Novel Role of
Bu F; Zhu X; Zhu J; Liu Z; Wu T; Luo C; Lin K; Huang J
Cancer Manag Res; 2020; 12():11677-11687. PubMed ID: 33235499
[TBL] [Abstract][Full Text] [Related]
17. GINS1 Induced Sorafenib Resistance by Promoting Cancer Stem Properties in Human Hepatocellular Cancer Cells.
Li S; Wu L; Zhang H; Liu X; Wang Z; Dong B; Cao G
Front Cell Dev Biol; 2021; 9():711894. PubMed ID: 34414190
[TBL] [Abstract][Full Text] [Related]
18. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
Ye Z; Jiang Y; Wu J
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
[TBL] [Abstract][Full Text] [Related]
19. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
20. MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.
Yuan C; Xiang L; Bai R; Cao K; Gao Y; Jiang X; Zhang N; Gong Y; Xie C
Ann Transl Med; 2019 Jun; 7(12):263. PubMed ID: 31355230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
